Vipin K Garg Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Vipin K Garg.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Vipin K Garg. Vipin K Garg is President & C.E.O. in Ocera Therapeutics, Inc. ($TZYM) and Chief Financial Officer in Altimmune, Inc. ($ALT) and President & CEO in Altimmune, Inc. ($ALT) and President and CEO in Altimmune, Inc. ($ALT) and Chief Executive Officer in Neos Therapeutics, Inc. ($NEOS) and President, CEO & Director in Neos Therapeutics, Inc. ($NEOS).
Latest Insider Trading Transactions of Vipin K Garg
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALT, NEOS, TZYM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 04 2021 | ALT | Altimmune, Inc. | Garg Vipin K | President and CEO | Payment of Exercise | F | 14.47 | 1,999 | 28,926 | 307,183 | 309.2 K to 307.2 K (-0.65 %) |
Mar 31 2021 | ALT | Altimmune, Inc. | Garg Vipin K | President and CEO | Payment of Exercise | F | 13.55 | 1,998 | 27,073 | 309,182 | 311.2 K to 309.2 K (-0.64 %) |
Mar 01 2021 | ALT | Altimmune, Inc. | Garg Vipin K | President and CEO | Payment of Exercise | F | 15.94 | 1,998 | 31,848 | 311,180 | 313.2 K to 311.2 K (-0.64 %) |
Feb 01 2021 | ALT | Altimmune, Inc. | Garg Vipin K | President and CEO | Payment of Exercise | F | 14.28 | 2,353 | 33,601 | 312,123 | 314.5 K to 312.1 K (-0.75 %) |
Jan 04 2021 | ALT | Altimmune, Inc. | Garg Vipin K | President and CEO | Payment of Exercise | F | 11.30 | 3,025 | 34,183 | 314,476 | 317.5 K to 314.5 K (-0.95 %) |
Dec 02 2020 | ALT | Altimmune, Inc. | Garg Vipin K | President and CEO | Payment of Exercise | F | 12.23 | 2,243 | 27,432 | 317,501 | 319.7 K to 317.5 K (-0.70 %) |
Oct 02 2020 | ALT | Altimmune, Inc. | Garg Vipin K | President & CEO | Payment of Exercise | F | 13.20 | 2,015 | 26,598 | 321,759 | 323.8 K to 321.8 K (-0.62 %) |
Aug 31 2020 | ALT | Altimmune, Inc. | Garg Vipin K | President & CEO | Payment of Exercise | F | 17.62 | 2,015 | 35,504 | 323,774 | 325.8 K to 323.8 K (-0.62 %) |
Aug 04 2020 | ALT | Altimmune, Inc. | Garg Vipin K | Chief Financial Off ... | Grant | A | 1.46 | 11,674 | 17,044 | 325,789 | 314.1 K to 325.8 K (+3.72 %) |
Aug 03 2020 | ALT | Altimmune, Inc. | Garg Vipin K | President and CEO | Payment of Exercise | F | 26.06 | 2,015 | 52,511 | 314,115 | 316.1 K to 314.1 K (-0.64 %) |
Jul 01 2020 | ALT | Altimmune, Inc. | Garg Vipin K | President and CEO | Payment of Exercise | F | 10.71 | 2,015 | 21,581 | 316,130 | 318.1 K to 316.1 K (-0.63 %) |
Jun 02 2020 | ALT | Altimmune, Inc. | Garg Vipin K | President and CEO | Payment of Exercise | F | 9.28 | 2,015 | 18,699 | 318,145 | 320.2 K to 318.1 K (-0.63 %) |
May 04 2020 | ALT | Altimmune, Inc. | Garg Vipin K | President and CEO | Payment of Exercise | F | 3.05 | 2,015 | 6,146 | 320,160 | 322.2 K to 320.2 K (-0.63 %) |
Apr 01 2020 | ALT | Altimmune, Inc. | Garg Vipin K | President and CEO | Payment of Exercise | F | 3.02 | 2,016 | 6,088 | 322,175 | 324.2 K to 322.2 K (-0.62 %) |
Feb 04 2020 | ALT | Altimmune, Inc. | Garg Vipin K | President and CEO | Grant | A | 1.46 | 11,289 | 16,482 | 326,206 | 314.9 K to 326.2 K (+3.58 %) |
Feb 03 2020 | ALT | Altimmune, Inc. | Garg Vipin K | President and CEO | Payment of Exercise | F | 1.77 | 2,015 | 3,567 | 314,917 | 316.9 K to 314.9 K (-0.64 %) |
Jan 03 2020 | ALT | Altimmune, Inc. | Garg Vipin K | President and CEO | Option Exercise | A | 1.92 | 149,500 | 287,234 | 149,500 | |
Jan 02 2020 | ALT | Altimmune, Inc. | Garg Vipin K | President and CEO | Payment of Exercise | F | 1.80 | 1,999 | 3,598 | 316,932 | 318.9 K to 316.9 K (-0.63 %) |
Dec 03 2019 | ALT | Altimmune, Inc. | Garg Vipin K | President and CEO | Payment of Exercise | F | 1.82 | 23,976 | 43,636 | 318,931 | 342.9 K to 318.9 K (-6.99 %) |
Sep 05 2019 | ALT | Altimmune, Inc. | Garg Vipin K | President and CEO | Buy | P | 2.10 | 20,000 | 42,000 | 342,907 | 322.9 K to 342.9 K (+6.19 %) |
Dec 04 2018 | ALT | Altimmune, Inc. | Garg Vipin K | President and CEO | Option Exercise | A | 3.59 | 111,421 | 400,001 | 111,421 | |
Dec 04 2018 | ALT | Altimmune, Inc. | Garg Vipin K | President and CEO | Option Exercise | A | 3.59 | 211,486 | 759,235 | 211,486 | |
Dec 04 2018 | ALT | Altimmune, Inc. | Garg Vipin K | President and CEO | Grant | A | 0.00 | 322,907 | 0 | 322,907 | 0 to 322.9 K |
Mar 05 2018 | NEOS | Neos Therapeutics, ... | Garg Vipin K | Chief Executive Off ... | Option Exercise | A | 8.30 | 75,000 | 622,500 | 75,000 | |
Mar 05 2018 | NEOS | Neos Therapeutics, ... | Garg Vipin K | Chief Executive Off ... | Grant | A | 0.00 | 25,000 | 0 | 160,748 | 135.7 K to 160.7 K (+18.42 %) |
Oct 17 2017 | NEOS | Neos Therapeutics, ... | Garg Vipin K | Chief Executive Off ... | Payment of Exercise | F | 8.00 | 14,895 | 119,160 | 135,748 | 150.6 K to 135.7 K (-9.89 %) |
May 02 2017 | NEOS | Neos Therapeutics, ... | Garg Vipin K | Chief Executive Off ... | Option Exercise | A | 7.00 | 75,000 | 525,000 | 75,000 | |
May 02 2017 | NEOS | Neos Therapeutics, ... | Garg Vipin K | Chief Executive Off ... | Grant | A | 0.00 | 25,000 | 0 | 150,643 | 125.6 K to 150.6 K (+19.90 %) |
Oct 18 2016 | NEOS | Neos Therapeutics, ... | Garg Vipin K | Chief Executive Off ... | Payment of Exercise | F | 6.37 | 9,709 | 61,846 | 125,643 | 135.4 K to 125.6 K (-7.17 %) |
Oct 04 2016 | NEOS | Neos Therapeutics, ... | Garg Vipin K | Chief Executive Off ... | Option Exercise | A | 10.74 | 62,500 | 671,250 | 87,500 | |
Apr 01 2016 | NEOS | Neos Therapeutics, ... | Garg Vipin K | Chief Executive Off ... | Option Exercise | A | 10.74 | 100,000 | 1,074,000 | 100,000 | |
Oct 19 2015 | NEOS | Neos Therapeutics, ... | Garg Vipin K | Chief Executive Off ... | Payment of Exercise | F | 18.54 | 9,197 | 170,512 | 135,352 | 144.5 K to 135.4 K (-6.36 %) |
Sep 03 2015 | NEOS | Neos Therapeutics, ... | Garg Vipin K | Chief Executive Off ... | Option Exercise | A | 25.50 | 201,259 | 5,132,105 | 201,259 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Garg Vipin K | President, CEO & Di ... | Option Exercise | C | 0.00 | 6,000 | 0 | 0 | |
Jul 28 2015 | NEOS | Neos Therapeutics, ... | Garg Vipin K | President, CEO & Di ... | Buy | C | 0.00 | 2,500 | 0 | 144,549 | 142 K to 144.5 K (+1.76 %) |
Apr 21 2011 | TZYM | Ocera Therapeutics ... | Garg Vipin K | President & C.E.O. | Option Exercise | A | 4.00 | 590,089 | 2,360,356 | 590,089 |
Page: 1